Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Utah for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Utah only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Utah (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Gee (NPI 1831372499)

Field	Value
Entity Type	Individual
Organization	Christopher Gee
Address	3855 W 7800 S Ste 100
City	West Jordan
State	UT
ZIP	84088
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	December 6, 2007

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the dataset: lifetime Medicare revenue is $1.9M while Medicaid revenue is none (no Medicaid billing on file). The absence of Medicaid activity indicates the practice’s Medicare population drives nearly all recorded public‑payer revenue. This concentration has implications for payer negotiation and case mix that are skewed toward older beneficiaries.

Revenue is highly concentrated in a small number of high‑cost injectable drugs: J2777 ($873.5K, 45.5% of Medicare revenue), J0178 ($284.8K, 14.8%), and J3490 ($199.9K, 10.4%) together account for 70.8% of the provider’s Medicare revenue. That precomputed top‑3 share signals dependence on a narrow set of therapeutic products for the majority of billed Medicare dollars.

Clinical mix and service line behavior are consistent with a retina specialist whose practice is injection‑centric: J2777 shows 30.1K claims, J2781 has 1.4K claims, J2778 875 claims, and J0178 414 claims, while 67028 (intravitreal injection procedure) appears with 1K claims. In addition, diagnostic imaging codes such as 92134 (1.2K claims) and angiography 92235 are present, indicating routine imaging and follow‑up of retinal disease alongside frequent intravitreal therapy. These code volumes point to a procedural ophthalmology practice focused on medical retina management rather than surgical retina.

The provider’s national competitive standing is mixed across top drugs: J2777 ranks #296 of 2039 (86th percentile; typical, unremarkable volume for this code), indicating higher‑than‑median national placement but labeled as typical in the supplied comparative language. By contrast J0178 ranks #2103 of 3204 (34th percentile; typical, unremarkable volume for this code), and J3490 ranks #651 of 2838 (77th percentile; typical, unremarkable volume for this code), so the provider shows stronger national presence for some agents and more modest participation for others.

Several supplemental codes show concentrated operational patterns: 92014 (established comprehensive exam) ranks #3640 of 35415 (90th percentile; typical, unremarkable volume for this code) and 92134 (retinal imaging) ranks #1858 of 26868 (93th percentile; typical, unremarkable volume for this code), suggesting a robust throughput of established Medicare patients receiving both exams and imaging. At the same time, 67042 (vitrectomy with internal limiting membrane peel) is rare (12 claims, $10.1K) and ranks #946 of 1087 (6th percentile; typical, unremarkable volume for this code), which indicates surgical retina is a minor component of billed activity.

The use of J3490 (unclassified drugs, $199.9K, 116 claims) and a nontrivial J7999 presence ($7.5K, 104 claims) signals some billing for drugs that fall outside standard named HCPCS lines or for compounded agents. Because J3490 and J7999 carry higher average paid/claim values in this file ($1723 avg for J3490), these lines materially affect revenue despite lower claim counts, and they may reflect episodic or specialty drug use that warrants attention in utilization reviews.

Tenure and stability indicators show a long‑standing NPI: the provider was enumerated 2007-12-06 (~19 years ago). That duration supports interpretation of these patterns as established rather than transient, and suggests any shifts in drug mix or volume would be observable against a long historical baseline.

From a payer management standpoint, the practice’s dependence on expensive biologic intravitreal injections as the primary revenue drivers—particularly J2777 at $873.5K (45.5%)—creates concentrated financial exposure for Medicare. Coupled with no Medicaid activity, this profile implies negotiation, utilization management, and prior‑authorization strategies should focus on high‑impact injectable agents and their clinical justification in an older Medicare population.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	30,120	$30	$873.5K
J0178	Injection, aflibercept, 1 mg	410	$690	$284.8K
J3490	Unclassified drugs	120	$1,720	$199.9K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,380	$120	$165.6K
J2778	Injection, ranibizumab, 0.1 mg	880	$180	$157.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,000	$90	$88.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	660	$80	$53.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,220	$30	$32.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	150	$100	$14.8K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	60	$190	$11.1K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Utah Distribution

Christopher Gee — 0 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Utah

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	24	40	620	$690	$683.2K
J2777	6	20	13,140	$30	$523.9K
J2778	5	10	870	$180	$224.3K
J3490	9	30	80	$1,690	$199.5K
J2781	4	20	960	$120	$126.6K
67028	15	60	440	$90	$61.7K
67042	13	20	20	$1,100	$26.3K
J7999	12	20	120	$70	$16.9K
92014	20	330	140	$70	$16.6K
92242	1	10	60	$190	$11.1K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Gee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Douglas Mehr	UT	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Andrew Davis	UT	Retina Specialist (Ophthalmology) Physician	$1.8M	$0
Rebekah Gensure	UT	Retina Specialist (Ophthalmology) Physician	$969.8K	$0
Salt Lake Retina, LLC	UT	Retina Specialist (Ophthalmology) Physician	$0	$768.8K

Nearby Providers

Other providers in the same ZIP code as Christopher Gee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Utah Homecare LLC	UT	Home Health Agency	$0	$14.9M
Jordan Valley Medical Center LP	UT	Rehabilitation Hospital Unit	$0	$9.1M
Affinity Behavior And Mental Health Services, LLC	UT	Community/Behavioral Health Agency	$0	$7.4M
Jordan Valley Medical Center LP	UT	General Acute Care Hospital	$0	$7.3M
Wasatch Pediatrics, Inc	UT	Pediatrics Physician	$0	$5.8M
Family Surgical Suite	UT	Ambulatory Surgical Clinic/Center	$0	$4.8M
Kids Behavioral Health Of Utah, Inc	UT	Emotionally Disturbed Childrens' Residential Treatment Facility	$0	$4.1M
Jordan West Family Counseling Inc	UT	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$1M
Valued Medical Care LLC	UT	Urgent Care Clinic/Center	$0	$836.2K
Southwest Children's Clinic	UT	Specialist	$0	$700.5K

Christopher Gee — Billing Profile & Reimbursement Data

Sign up for Christopher Gee — Billing Profile & Reimbursement Data policy alerts

Christopher Gee — Billing Profile & Reimbursement Data

Sign up for Christopher Gee — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References